The treatment of peritonitis by an antiseptic - taurolin

An open study was carried out on patients with acute appendicitis to assess the effectiveness of taurolin, a new antiseptic which destroys both bacteria and endotoxin, when used intraperitoneally in cases of purulent peritonitis associated with perforated or gangrenous appendicitis. Seventy-four out...

Description complète

Détails bibliographiques
Publié dans:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 2(1981), 8 vom: 16., Seite 517-22
Auteur principal: Browne, M K (Auteur)
Format: Article
Langue:English
Publié: 1981
Accès à la collection:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Sujets:Journal Article Anti-Infective Agents, Local Endotoxins Thiadiazines Thiazines Taurine 1EQV5MLY3D taurolidine 8OBZ1M4V3V
Description
Résumé:An open study was carried out on patients with acute appendicitis to assess the effectiveness of taurolin, a new antiseptic which destroys both bacteria and endotoxin, when used intraperitoneally in cases of purulent peritonitis associated with perforated or gangrenous appendicitis. Seventy-four out of 319 patients received taurolin; the others were treated by operation only or by operation and antibiotics as required. The results suggest that taurolin was effective as monotherapy in peritonitis and endotoxic shock and its use avoids the problems associated with antibiotics
Description:Date Completed 25.09.1981
Date Revised 21.11.2013
published: Print
Citation Status MEDLINE